Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barre syndrome

Cellular and Molecular Life Sciences

Volumn 57, Issue 4, 2000, Pages 527-533

  Yuki, N ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Campylobacter jejuni; Ganglioside; Guillain Barre syndrome; Lipopolysaccharide; Miller Fisher syndrome; Molecular mimicry

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; GANGLIOSIDE GQ 1B; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

CAMPYLOBACTER JEJUNI; DISEASE COURSE; ENTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOGLOBULIN PRODUCTION; MOLECULAR MIMICRY; MOTOR NERVE BLOCK; NONHUMAN; OPHTHALMOPLEGIA; PERIPHERAL NEUROPATHY; REVIEW; SUBCLAVIAN STEAL SYNDROME;

EID: 0034107882     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000714     Document Type: Review

References (66)

1. 1 Hughes R. A. and Rees J. H. (1997) Clinical and epidemiologic features of Guillain-Barré syndrome. J. Infect. Dis. 176(Suppl 2): S92-S98
2. 2 Jacobs B. C., Rothbarth P. H., Meché F. G. A. van der, Herbrink P., Schmitz P. I., Klerk M. A. de et al. (1998) The spectrum of antecedent infections in Guillain-Barré syndrome: a case control study. Neurology 51: 1110-1115
3. 3 Thornton C. A. and Griggs R. C. (1994) Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann. Neurol. 35: 260-268
4. 4 Hafer-Macko C., Hsieh S. T., Li C. Y., Ho T. W., Sheikh K., Cornblath D. R. et al. (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40: 635-644
5. 5 Hartung H.-P., Pollard J. D., Harvey G. K. and Toyka K. V. (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome. I. Muscle Nerve 18: 137-153
6. 6 Freddo L., Yu R. K., Latov N., Donofrio P. D., Hays A. P., Greenberg S. et al. (1986) Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 36: 454-458
7. 7 Pestronk A., Cornblath D. R., Ilyas A. A., Baba H., Quarles R. H., Griffin J. W. et al. (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann. Neurol. 24: 73-78
8. 8 Ilyas A. A., Willison H. J., Quarles R. H., Jungalwala F. B., Cornblath D. R., Trapp B. D. et al. (1988) Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann. Neurol. 23: 440-447
9. 9 Inuzuka T., Miyatani N., Baba H., Tanaka M., Tanaka K., Sato S. et al. (1988) IgM binding to sialosyllactosaminylparagloboside in a patient with polyradiculopathy due to Mycoplasma pneumoniae infection. Acta Neurol. Scand. 78: 53-57
10. 10 Yuki N., Yoshino H., Sato S. and Miyatake T. (1990) Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campyhbacter enteritis. Neurology 40: 1900-1902
11. 11 Kornberg A. J., Pestronk A., Bieser K., Ho T. W., McKhann G. M., Wu H. S. et al. (1994) The clinical correlates of high-liter IgG anti-GM1 antibodies. Ann. Neurol. 35: 234-237
12. 12 Rees J. H., Gregson N. A. and Hughes R. A. C. (1995) Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38: 809-816
13. 13 Visser L. H., Meché F. G. A. van der, Dorn P. A. van, Meuistee J., Jacobs B. C, Oomes P. G. et al. (1995) Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 118: 841-847
14. 14 Yuki N., Sato S., Miyatake T., Sugiyama K., Kalagiri T. and Sasaki H. (1991) Motoneuron-disease-like disorder after ganglioside therapy. Lancet 337: 1109-1110
15. 15 Latov N., Koski C. L. and Walicke P. A. (1991) Guillain-Barré syndrome and parenteral ganglioside. Lancet 338: 757
16. 16 Schönhöfer P. S. (1991) Guillain-Barré syndrome and parenteral ganglioside. Lancet 338: 757
17. 17 Kuroki S., Haruta T., Yoshioka M., Kobayashi Y., Nukina M., Nakanishi H. et al. (1991) Guillain-Barré syndrome associated with Campylobacter infection. Pediatr. Infect. Dis. 10: 149-151
18. 18 Yuki N., Sato S., Fujimoto S., Yamada S., Tsujino Y., Kinoshita A. et al. (1992) Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome. Muscle Nerve 15: 968-969
19. 19 Yuki N., Handa S., Taki T., Kasama T., Takahashi M., Saito K. et al. (1992) Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between ganglioside GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed. Res. 13: 451-453
20. 20 Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K. et al. (1993) A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178: 1771-1775
21. 21 Wirguin I., Suturkova-Milosevic L., Della-Latta P., Fisher T., Brown R. H. Jr, Latov N. et al. (1994) Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann. Neurol. 35: 698-703
22. 22 Oomes P. G., Jacobs B. C., Hazenberg M. P. H., Bänffer J. R. J. and Meché F. G. A. van der (1995) Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann. Neurol. 38: 170-175
23. 23 Willison H. J. and Veitch J. (1994) Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 50: 159-165
24. 24 Yuki N., Ichihashi Y. and Taki T. (1995) Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J. Neuroimmunol. 60: 161-164
25. 25 Aspinall G. O., McDonald A. G., Raju T. S., Pang H., Woran A. P. and Penner J. L. (1993) Chemical structures of the core regions of Campylobactfer jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur. J. Biochem. 213: 1017-1027
26. 26 Yuki N., Taki T., Takahashi M., Saito K., Tai T., Miyatake T. et al. (1994) Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears GD1a epitope. Infect. Immun. 62: 2101-2103
27. 27 Aspinall G. O., McDonald A. G., Pang H., Kurjanczyk L. A. and Penner J. L. (1994) Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with Guillain-Barré syndrome. Biochemistry 33: 241-249
28. 28 Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y. et al. (1993) Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33: 243-247
29. 29 Rees J. H., Soudain S. E., Gregson N. A. and Hughes R. A. C. (1995) Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333: 1374-1379
30. 30 Yuki N., Takahashi M., Tagawa Y., Kashiwase K., Tadokoro K., Saito K. et al. (1997) Association of Campylobacter jejuni serotype with anti-ganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Ann. Neurol. 42: 28-33
31. 31 Aspinall G. O., McDonald A. G. and Pang H. (1994) Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33: 250-255
32. 32 Hansen C., Otto E., Kuhlemann K., Forster G. and Kahuly G. J. (1996) Glycosaminoglycans in autoimmunity. Clin. Exp. Rheumatol. 14(Suppl. 15): S59-S67
33. 33 Nachamkin I., Ung H., Moran A. P., Yoo D., Prendergast M. M., Nicholson M. A. et al. (1999) Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J. Infect. Dis. 179: 1183-1189
34. 34 Schluep M. and Steck A. J. (1988) Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease. Neurology 38: 1890-1892
35. 35 Corbo M., Quattrini A., Latov N. and Hays A. (1993) Localization of GM1 and Gal(β1 3)GalNAc antigenic determinants in peripheral nerve. Neurology 43: 809-814
36. 36 Thomas F. P., Trojaborg W., Nagy C., Santoro M., Sadiq S. A., Latov N. et al. (1991) Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. 82: 378-383
37. 37 Santoro M., Uncini A., Corbo M., Staugaitis S. M., Thomas F. P., Hays A. P. et al. (1992) Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann. Neurol. 31: 385-390
38. 38 Uncini A., Santoro M., Corbo M., Lugaresi A. and Latov N. (1993) Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16: 610-615
39. 39 Arasaki K., Kusunoki S., Kudo N. and Kanazawa I. (1993) Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 16: 587-593
40. 40 Roberts M., Willison H. J., Vincent A. and Newsom-Davis J. (1995) Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann. Neurol. 37: 436-442
41. + currents in isolated rat myelinated nerve fibers. Ann. Neurol. 37: 436-442
42. 42 Hirota N., Kaji R., Boslock H., Shindo K., Kawasaki T., Mizutani K. et al. (1997) The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 120: 2159-2169
43. 43 Harvey G. K., Toyka K. V., Zielasek J., Kiefer R., Simonis C. and Hartung H. P. (1995) Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 18: 388-394
44. 44 Kobayashi T., Michikawa M., Park-Matsumoto Y. C., Kameda N., Yuki N. and Miyatake T. (1993) Inhibition of motor neuron excitability by serum with anti-GM1 & GM2 antibodies and their monoclonal ones. Can. J. Neurol. Sci. 20(Suppl. 4): S134
45. 45 Kusunoki S., Chiba A., Kon K., Ando S., Ansawa K., Tate A. et al. (1994) N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 35: 570-576
46. 46 Yuki N., Taki T. and Handa S. (1996) Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Neuroimmunol. 71: 155-161
47. 47 Landi G., D'Alessandro R., Dossi B. C., Ricci S., Simone I. L. and Ciccone A. (1993) Guillain-Barré syndrome after exogeneous gangliosides in Italy. BMJ 307: 1463-1464
48. 48 Hirabayashi Y., Hyogo A., Nakao T., Tsuchiya K., Suzuki Y., Matsumoto M. et al. (1990) Isolation and characterization of extremely minor gangliosides, GM1b and GD1α, in adult bovine brains as developmentally regulated antigens. J. Biol. Chem. 265: 8144-8151
49. 49 Kusunoki S., Iwamori M., Chiba A., Hitoshi S., Arita M., Kanazawa I. et al. (1996) GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology 47: 237-242
50. 50 Yuki N., Tagawa Y., Irie F., Hirabayashi Y. and Handa S. (1997) Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J. Neuroimmunol. 74: 30-34
51. 51 Rees J. H., Vaughan R. W., Kondeatis E. and Hughes R. A. C. (1995) HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J. Neuroimmunol. 62: 53-57
52. 52 Koga M., Yuki N., Kashiwase K., Tadokoro K., Juji T. and Hirata K. (1998) Guillain-Barré and Fisher' syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies. J. Neuroimmunol. 88: 62-66
53. 53 Ma J. J., Nishimura M., Mine H., Kuroki S., Nukina M., Ohta M. et al. (1998) HLA and T-cell receptor gene polymorphisms in Guillain-Barré sundrome. Neurology 51: 379-384
54. 54 Li C. Y., Tian W. Q., Liu R. C. and Yang C. (1996) Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 61: 279-284
55. 55 Griffin J. W., Li C. Y., Ho T. W., Tian M., Gao C. Y., Xue P. et al. (1996) Pathology of motor-sensory axonal Guillain-Barré syndrome. Ann. Neurol. 39: 17-28
56. 56 Illa I., Ortiz N., Gallard E., Juarez C., Grau J. M. and Dalakas M. C. (1995) Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol. 38: 218-224
57. 57 Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M. et al. (1998) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann. Neurol. 44: 202-208
58. 58 Yuki N. (1998) Anti-ganglioside antibody and neuropathy: review of our research. J. Periph. Nerv. Syst. 3: 3-18
59. 59 Chiba A., Kusunoki S., Shimizu T. and Kanazawa I. (1992) Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31: 677-679
60. 60 Willison H. J., Veitch J., Paterson G. and Kennedy P. G. E. (1993) Miller Fisher syndrome is associated with antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry 56: 204-206
61. 61 Yuki N., Sato S., Tsuji S., Ohsawa T. and Miyatake T. (1993) Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43: 414-417
62. 62 Chiba A., Kusunoki S., Obata H., Machinami R. and Kanazawa I. (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43: 1911-1917
63. 63 Takano H. and Yuki N. (1995) Fisher's syndrome associated with chickenpox and anti-GQ1b antibody. J. Neurol. 242: 255-256
64. 64 Yuki N., Ichikawa H. and Doi A. (1995) Fisher syndrome after Campylobacter jejuni enteritis: human leukocyte antigen and the bacterial serotype. J. Pediatr. 126: 55-57
65. 65 Yuki N., Taki T., Takahashi M., Saito K., Yoshino H., Tai T. et al. (1994) Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36: 791-793
66. 66 Jacobs B. C., Endtz H. Ph., Meché F. G. A. van der, Hazenberg M. P., Achtereckte H. A. and Doorn P. A. van (1995) Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann. Neurol. 37: 260-264